1. Gisler RH, Schumann G, Sackmann W, Pericin C, Tarcsay L, Dietrich FM. A novel muramyl peptide, MTP-PE: profile of biological activities. In: Yamamura Y, Kotani S, eds. Immunomodulation by microbial products and related synthetic compounds. Excerpta Medica 1982; 167–70.
2. Ellouz FG, Adam A, Ciorbaru R, Lederer E. Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochem Biophys Res Commun 1974; 59: 1317–25.
3. Kotani S, Watanabe Y, Kinoshita F, et al. Immunoadjuvant activities of synthetic N-acetyl-muramylpeptides or amino acids. Biken J 1975; 18: 105–11.
4. Schumann G, van Hoogevest P, Fankhauser P, et al. Comparison of free and liposomal MTP-PE: pharmacological, toxicological and pharmacokinetic aspects. In: Lopez-Berestein G, Fidler IJ, eds. Liposomes in the therapy of infectious diseases and cancer, UCLA Symposia on Molecular and Cellular Biology, New Series, New York: Alan R. Liss, 1989; 89: 191–203.
5. Bangham AD. membrane models with phospholipids. Progr Biophys Mol Biol 1968; 18: 29–95.